The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

Background Preclinical evidence shows that short-term fasting (STF) protects healthy cells against side effects of chemotherapy and makes cancer cells more vulnerable to it. This pilot study examines the feasibility of STF and its effects on tolerance of chemotherapy in a homogeneous patient group w...

Full description

Saved in:

Bibliographic Details
Published in:	BMC cancer Vol. 15; no. 1; p. 652
Main Authors:	de Groot, Stefanie, Vreeswijk, Maaike PG, Welters, Marij JP, Gravesteijn, Gido, Boei, Jan JWA, Jochems, Anouk, Houtsma, Daniel, Putter, Hein, van der Hoeven, Jacobus JM, Nortier, Johan WR, Pijl, Hanno, Kroep, Judith R
Format:	Journal Article
Language:	English
Published:	London BioMed Central 05.10.2015 BioMed Central Ltd Springer Nature B.V
Subjects:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - mortality Breast Neoplasms - pathology Calories Cancer Research Care and treatment Chemotherapy Cloning Comparative analysis Complications and side effects DNA Damage Fasting Female Growth factors Health aspects Health Promotion and Disease Prevention Histones - metabolism Human subjects Humans Insulin Laboratories Leukocytes, Mononuclear - metabolism Medicine/Public Health Metabolism Middle Aged Neoadjuvant Therapy Neoplasm Grading Neoplasm Staging Oncology Patients Pilot Projects Receptor, ErbB-2 - deficiency Research Article Surgical Oncology Time Factors Toxicity Treatment Outcome Chemotherapy Toxicity Early stage breast cancer DNA damage Short-term fasting
ISSN:	1471-2407, 1471-2407
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!